The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

The FDA has approved the first pill version of Wegovy, expanding access to one of the most popular and effective weight-loss ...

Beginning in January 2026, this pill - developed by Danish pharmaceutical company Novo Nordisk - will become a daily option ...

The FDA on Monday approved a daily pill version of Novo Nordisk’s Wegovy, making it the first oral GLP-1 obesity treatment ...

There’s “quite big news” around weight loss medications circulating right now, says Wajahat Mehal, MD, director of Yale ...

Across social media and encrypted messaging apps, a new frontier of weight loss is unfolding in real time, with people sourcing and injecting an experimental drug that regulators have not yet approved ...

Weight-loss injections are being hailed as a modern medical breakthrough, but experts warn they are not cosmetic quick fixes. Designed to treat metabolic disease, these drugs require careful screening ...

A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for ...

The post Wegovy Wins First Weight-Loss Pill Approval appeared first on Self Employed.

The FDA has approved the first-ever Wegovy pill for weight loss, with the oral GLP-1 offering a 16.6% average weight ...

Eli Lilly and Novo Nordisk — the dominant players in obesity drug development — each submitted a new weight-loss drug to the ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat healthily and exercise regularly. Injectable weight loss medications — also ...